Syncom Formulations (India) Limited — Results, 10-02-2025: Integrated Filing- Financial

SYNCOM FORMULATIONS (INDIA) LIMITED has announced a board meeting to discuss the financial results for the quarter and nine months ended December 31, 2024. The company reported a total income of ₹31,613.62 lakh and a profit before tax of ₹3,174.03 lakh, reflecting solid operational performance. Earnings per share for continuing operations stand at ₹0.41, underscoring effective cost management.

This update highlights the company's robust financial health and growth trajectory, which could enhance investor sentiment and present opportunities for long-term growth in a competitive market. Overall, the outlook remains positive, with strong fundamentals supporting further expansion and value creation.